Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

Delayed Data
As of Oct 26
 +0.02 / +0.05%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 47.21, with a high estimate of 53.03 and a low estimate of 35.10. The median estimate represents a +17.04% increase from the last price of 40.34.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Hold stock in GlaxoSmithKline. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.62%
Growthannually 10.91%


Growthquarterly 5.11%
Growthannually -2.91%
Key to the earnings and sales forecast charts.